Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Plymouth Meeting, PA
SEC filing record 1 source field available
Fiscal year end
31 December
INOVIO PHARMACEUTICALS, INC. has filed 1,289 SEC EDGAR filings since 29 Jun 1999

SEC filing history

Showing 401-425 of 873 matching filings.

Per page
25
Current page
17
EFFECT File 333-236202

EFFECT filing

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-60487

SC 13G

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-60487

SC 13G filing

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-60487

SCHEDULE 13G

Filing date
11 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60487

SC 13G/A filing

Filing date
10 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-225233

424B5

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

8-K

Filing date
07 Feb 2020
Reporting date
07 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60487

SC 13G/A filing

Filing date
05 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-236202

S-3

Filing date
31 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-236201

S-8

Filing date
31 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-358860

D filing

Filing date
24 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Jan 2020
Reporting date
15 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
16 Jan 2020
Reporting date
15 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

8-K

Filing date
15 Jan 2020
Reporting date
15 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jan 2020
Reporting date
03 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

8-K

Filing date
02 Jan 2020
Reporting date
26 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Dec 2019
Reporting date
05 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Sep 2019
Reporting date
30 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-346682

D filing

Filing date
15 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14888

8-K

Filing date
06 Aug 2019
Reporting date
31 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .